How do you ensure clinical trial access for all?

The virtual clinical trial space exploded during the COVID-19 pandemic. We chat to Medable founder & CEO Michelle Longmire to explore how her global platform empowers clinicians to develop patient-centric research strategies. We uncover how she’s coped with the rapid success that saw the company’s revenue grow by more than 500% in 2020, & what the future holds for decentralized clinical trials & digital endpoints.

Read: A letter from Michelle Longmire, CEO

See why we believe these results show the potential to greatly accelerate research beyond the status quo.

The first ever "Medable Matters" report

Read our 2021 Impact Report and see what’s coming in 2022.
Medcity Influencers, Pharmacy
Retail Pharmacies: the Key to Making Clinical Trials Accessible for Everybody?
JMIR Formative Research
Development of a Mobile Health App (TOGETHERCare) to Reduce Cancer Care Partner Burden: Product Design Study
Perspectives
At Medable's PAC, Patient Advocacy is Personal
Perspectives
Clinical's Crystal Ball: How the Decentralized Model Will Transform Patient Care
Watch On Demand
Overcome Perceived DCT and eCOA Adoption Hurdles
Clinical Trials Digital Week
Amplify Science with Patient-Centered Design and Experience
Perspectives
Improving Clinical Trial Diversity and Patient Access to Affordable Drugs
No items found.
Medable at DIA 2021
Decentralized Clinical Trials - Accelerate Drug Development Through Anytime, Anywhere Participation
The Building Blocks of DCT
No items found.